Liraglutide (T2DM)

Seven trials of antihyperglycemic agents from different classes have now been concluded as of May 2017. This review summarizes, compares, and contrasts the key cardiovascular (CV) and non-CV findings from these trials.

Herbst R, Bolton W, Shariff A, Green JB. Curr Diab Rep 2017;17:67. doi:10.1007/s11892-017-0898-8

In this review, Kovatchev discusses topics related to the assessment, quantification, and optimal control of glucose fluctuations in diabetes mellitus which are crucial for providing accurate information to the patient and physician.

Nat Rev Endocrinol 2017;13:425–436. doi:10.1038/nrendo.2017.3

The authors discuss the prevalence of obesity and type 2 diabetes in children and adolescents and summarize published studies on the safety and effectiveness of antihyperglycemic medications in this population.

Akhlaghi F et al. Clin Pharmacokinet 2017; 56: 561–571. doi:10.1007/s40262-016-0472-6